An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

od Schwartz, Jennifer A., Prado, Ilia, Misamore, Johnathan, Weiss, Deborah, Francis, Jesse, Pal, Ranajit, Huaman, Maria, Cristillo, Anthony, Lewis, George K., Gallo, Robert C., DeVico, Anthony L., Fouts, Timothy R.
Izdano u Clin Vaccine Immunol (2016)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

od Pittala, Srivamshi, Bagley, Kenneth, Schwartz, Jennifer A, Brown, Eric P, Weiner, Joshua A, Prado, Ilia J, Zhang, Wenlei, Xu, Rong, Ota‐Setlik, Ayuko, Pal, Ranajit, Shen, Xiaoying, Beck, Charles, Ferrari, Guido, Lewis, George K, LaBranche, Celia C, Montefiori, David C, Tomaras, Georgia D, Alter, Galit, Roederer, Mario, Fouts, Timothy R, Ackerman, Margaret E, Bailey‐Kellogg, Chris
Izdano u Mol Syst Biol (2019)

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

od Fouts, Timothy R., Bagley, Kenneth, Prado, Ilia J., Bobb, Kathryn L., Schwartz, Jennifer A., Xu, Rong, Zagursky, Robert J., Egan, Michael A., Eldridge, John H., LaBranche, Celia C., Montefiori, David C., Le Buanec, Hélène, Zagury, Daniel, Pal, Ranajit, Pavlakis, George N., Felber, Barbara K., Franchini, Genoveffa, Gordon, Shari, Vaccari, Monica, Lewis, George K., DeVico, Anthony L., Gallo, Robert C.
Izdano u Proc Natl Acad Sci U S A (2015)

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

od Chua, Joel V., Davis, Charles, Husson, Jennifer S., Nelson, Amy, Prado, Ilia, Flinko, Robin, Lam, Ka Wing J., Mutumbi, Lydiah, Mayer, Bryan T., Dong, Dan, Fulp, William, Mahoney, Celia, Gerber, Monica, Gottardo, Raphael, Gilliam, Bruce L., Greene, Kelli, Gao, Hongmei, Yates, Nicole, Ferrari, Guido, Tomaras, Georgia, Montefiori, David, Schwartz, Jennifer A., Fouts, Timothy, DeVico, Anthony L., Lewis, George K., Gallo, Robert C., Sajadi, Mohammad M.
Izdano u Vaccine (2021)

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIV(mac251) Acquisition

od Gordon, Shari N., Liyanage, Namal P. M., Doster, Melvin N., Vaccari, Monica, Vargas-Inchaustegui, Diego A., Pegu, Poonam, Schifanella, Luca, Shen, Xiaoying, Tomaras, Georgia D., Rao, Mangala, Billings, Erik A., Schwartz, Jennifer, Prado, Ilia, Bobb, Kathryn, Zhang, Wenlei, Montefiori, David C., Foulds, Kathryn E., Ferrari, Guido, Robert-Guroff, Marjorie, Roederer, Mario, Phan, Tran B., Forthal, Donald N., Stablein, Donald M., Phogat, Sanjay, Venzon, David J., Fouts, Timothy, Franchini, Genoveffa
Izdano u J Immunol (2016)